Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline
DRUG
2 trials
Sponsors
Sandoz
, Medical University of Vienna
Conditions
Depression
Major Depressive Disorder (MDD)
Phase 1
A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions
Completed
NCT00864981
Sandoz
Depression
Start: 2005-09-30
End: 2005-10-31
Updated: 2017-03-29
Phase 4
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
Recruiting
NCT06675851
Medical University of Vienna
Major Depressive Disorder (MDD)
Start: 2022-12-01
End: 2026-12-31
Target: 120
Updated: 2024-11-05
Related Papers
Test-Retest Reliability of Dopaminergic fPET and fMRI Measures During Reward Processing.
2026-06-09